Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Tumor necrosis factor1477 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A47215 | 22538404 | Am J Physiol Gastrointest Liver Physiol | Arachidonic acid stimulates TNFα production in Kupffer cells via a reactive oxygen species-pERK1/2-Egr1-dependent mechanism. | 2012 | Details |
A47222 | 22413959 | Alcohol Clin Exp Res | Carvedilol attenuates the progression of alcohol fatty liver disease in rats. | 2012 | Details |
A47230 | 22169690 | Zhonghua Yu Fang Yi Xue Za Zhi | [The effects of NF-E2-related factor-2 prompter polymorphism on alcoholic liver disease with Vibrio vulnificus sepsis]. | 2011 | Details |
A47237 | 21826088 | Nat Rev Gastroenterol Hepatol | Alcoholic liver disease: pathogenesis and new targets for therapy. | 2011 | Details |
A47242 | 21673994 | PLoS One | Catechin suppresses an array of signalling molecules and modulates alcohol-induced endotoxin mediated liver injury in a rat model. | 2011 | Details |
A47249 | 21423135 | Lab Invest | Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells. | 2011 | Details |
A47258 | 20955970 | Best Pract Res Clin Gastroenterol | Alcoholic steatohepatitis. | 2010 | Details |
A47261 | 20399524 | J Hepatol | Harmful effect of adipose tissue on liver lesions in patients with alcoholic liver disease. | 2010 | Details |
A47266 | 20041784 | J Med Food | Protective effect of Codonopsis lanceolata root extract against alcoholic fatty liver in the rat. | 2009 | Details |
A47275 | 19608736 | Am J Physiol Gastrointest Liver Physiol | Pathological roles of bone marrow-derived stellate cells in a mouse model of alcohol-induced fatty liver. | 2009 | Details |
A47277 | 19588123 | Arch Toxicol | Ethanol and liver: recent advances in the mechanisms of ethanol-induced hepatosteatosis. | 2009 | Details |
A47278 | 19372631 | J Pharmacol Sci | Magnolia officinalis reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element-binding protein-1c. | 2009 | Details |
A47279 | 19371623 | Toxicol Appl Pharmacol | Honokiol reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element binding protein-1c and the expression of its downstream lipogenesis genes. | 2009 | Details |
A47281 | 19239162 | Adv Exp Med Biol | Effect of taurine on alcoholic liver disease in rats. | 2009 | Details |
A47290 | 19003881 | Hepatology | Ethanol and arachidonic acid synergize to activate Kupffer cells and modulate the fibrogenic response via tumor necrosis factor alpha, reduced glutathione, and transforming growth factor beta-dependent mechanisms. | 2008 | Details |
A47292 | 18722787 | Cytokine | Fat diet and alcohol-induced steatohepatitis after LPS challenge in mice: role of bioactive TNF and Th1 type cytokines. | 2008 | Details |
A47294 | 18599584 | Am J Physiol Gastrointest Liver Physiol | Hepatic macrophage iron aggravates experimental alcoholic steatohepatitis. | 2008 | Details |
A47297 | 18534708 | Diabetes Res Clin Pract | Fatty liver and chronic inflammation in Chinese adults. | 2008 | Details |
A47298 | 18509591 | Amino Acids | Effect of taurine on alcoholic liver disease in rats. | 2008 | Details |
A47301 | 18336673 | J Gastroenterol Hepatol | Cholesterol and sphingolipids in alcohol-induced liver injury. | 2008 | Details |
A47302 | 18395093 | Gastroenterology | Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury. | 2008 | Details |
A47304 | 18341647 | Alcohol Clin Exp Res | A voluntary oral ethanol-feeding rat model associated with necroinflammatory liver injury. | 2008 | Details |
A47305 | 18339590 | Dig Liver Dis | Inhibitory effect of osthole on alcohol-induced fatty liver in mice. | 2008 | Details |
A47309 | 17850215 | Alcohol Clin Exp Res | Lysosomal leakage and lack of adaptation of hepatoprotective enzyme contribute to enhanced susceptibility to ethanol-induced liver injury in female rats. | 2007 | Details |
A47312 | 17616758 | Am J Clin Nutr | Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium. | 2007 | Details |
A47316 | 17328242 | Arch Pharm Res | Altered activity of cytochrome P450 in alcoholic fatty liver exposed to ischemia/reperfusion. | 2007 | Details |
A47319 | 17203086 | Nat Clin Pract Gastroenterol Hepatol | Management strategies in alcoholic liver disease. | 2007 | Details |
A47323 | 17058832 | Zhongguo Zhong Xi Yi Jie He Za Zhi | [Relationship between alcoholic liver injury and endotoxin leakage from gut and intervention effect of jianpi liqi huoxue decoction]. | 2006 | Details |
A47326 | 16958678 | J Gastroenterol Hepatol | Unfolding new mechanisms of alcoholic liver disease in the endoplasmic reticulum. | 2006 | Details |
A47327 | 16958658 | J Gastroenterol Hepatol | Anti-adipogenic regulation underlies hepatic stellate cell transdifferentiation. | 2006 | Details |
A47335 | 16227360 | Gut | Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake. | 2005 | Details |
A47336 | 16170395 | Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub | High adiponectin and TNF-alpha levels in moderate drinkers suffering from liver steatosis: comparison with non drinkers suffering from similar hepatopathy. | 2005 | Details |
A47345 | 15368449 | Hepatology | Role of TNF-alpha in ethanol-induced hyperhomocysteinemia and murine alcoholic liver injury. | 2004 | Details |
A47352 | 14647036 | J Lab Clin Med | Ethyl pyruvate ameliorates acute alcohol-induced liver injury and inflammation in mice. | 2003 | Details |
A47362 | 12512042 | Gastroenterology | Peroxisome proliferator-activated receptor-beta signaling contributes to enhanced proliferation of hepatic stellate cells. | 2003 | Details |
A47383 | 10235499 | Arch Pathol Lab Med | The antigenic heterogeneity of the bile duct epithelium in alcoholic liver disease. VA Cooperative Study Group 275. | 1999 | Details |
A47388 | 9622456 | Alcohol Clin Exp Res | Altered T-lymphocyte responsiveness to polyclonal cell activators is responsible for liver cell necrosis in alcohol-fed rats. | 1998 | Details |
A47397 | 9397995 | Hepatology | Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alfa and reverse fibrosis in alcohol-induced liver disease in the rat. | 1997 | Details |
A47398 | 9309314 | Alcohol Clin Exp Res | Choline deficiency augments and antibody to tumor necrosis factor-alpha attenuates endotoxin-induced hepatic injury. | 1997 | Details |
A47404 | 9195371 | J Gastroenterol Hepatol | Ethanol feeding enhances inflammatory cytokine expression in lipopolysaccharide-induced hepatitis. | 1997 | Details |
A47407 | 8978360 | Gastroenterology | Thromboxane inhibitors attenuate pathological changes in alcoholic liver disease in the rat. | 1997 | Details |
A47421 | 8525652 | Z Gastroenterol | Tumor-necrosis-factor and interleukin-6 response of peripheral blood monocytes to low concentrations of lipopolysaccharide in patients with alcoholic liver disease. | 1995 | Details |
A47777 | 32108953 | Hepatology | Decreased Hepatocyte Autophagy Leads to Synergistic IL-1β and TNF Mouse Liver Injury and Inflammation. | 2020 | Details |
A47903 | 29619419 | Hepatol Commun | Tumor necrosis factor-α-mediated hepatocyte apoptosis stimulates fibrosis in the steatotic liver in mice. | 2018 | Details |
A47923 | 29191940 | Am J Physiol Gastrointest Liver Physiol | Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation. | 2017 | Details |
A47957 | 28236037 | Inflammopharmacology | PPARα/γ antagonists reverse the ameliorative effects of osthole on hepatic lipid metabolism and inflammatory response in steatohepatitic rats. | 2017 | Details |
A47974 | 27659424 | Am J Physiol Gastrointest Liver Physiol | Glycine prevents metabolic steatohepatitis in diabetic KK-Ay mice through modulation of hepatic innate immunity. | 2016 | Details |
A47980 | 27443844 | Mol Cell Biochem | A20 reduces lipid storage and inflammation in hypertrophic adipocytes via p38 and Akt signaling. | 2016 | Details |
A47999 | 26872435 | J Microbiol Immunol Infect | Serum pentraxin-3 and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) predict severity of infections in acute decompensated cirrhotic patients. | 2016 | Details |
A48009 | 26686910 | Reprod Toxicol | Anti-inflammatory potential of β-cryptoxanthin against LPS-induced inflammation in mouse Sertoli cells. | 2015 | Details |
A48010 | 26634212 | Biomed Res Int | The Influence of α-Lipoic Acid and Garlic Administration on Biomarkers of Oxidative Stress and Inflammation in Rabbits Exposed to Oxidized Nutrition Oils. | 2015 | Details |
A48079 | 24726754 | Gastroenterology | Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis. | 2014 | Details |
A48109 | 23226929 | Mediators Inflamm | Simulating sleep apnea by exposure to intermittent hypoxia induces inflammation in the lung and liver. | 2012 | Details |
A48136 | 21941003 | J Biol Chem | Death receptor 5 signaling promotes hepatocyte lipoapoptosis. | 2011 | Details |
A48161 | 20953409 | Vet Med Int | Lycopene prevents development of steatohepatitis in experimental nonalcoholic steatohepatitis model induced by high-fat diet. | 2010 | Details |
A48267 | 18032466 | Am J Physiol Regul Integr Comp Physiol | Attenuation of acute and chronic liver injury in rats by iron-deficient diet. | 2007 | Details |
A48272 | 17916356 | Gastroenterology | Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection. | 2007 | Details |
A48302 | 17023554 | Am J Physiol Gastrointest Liver Physiol | Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. | 2006 | Details |
A48326 | 16494792 | Zhonghua Gan Zang Bing Za Zhi | [Role of peroxisome proliferator activated receptor alpha in the pathogenesis of nonalcoholic steatohepatitis]. | 2006 | Details |
A48331 | 16344599 | Alcohol Clin Exp Res | Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4. | 2005 | Details |
A48357 | 15368448 | Hepatology | Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis. | 2004 | Details |
A48359 | 15329221 | Zhonghua Gan Zang Bing Za Zhi | [Expression of CD35 on erythrocyte and the changes of serum inflammatory cytokines in patients with nonalcoholic steatohepatitis and its immune regulation]. | 2004 | Details |
A48383 | 12866461 | Nihon Naika Gakkai Zasshi | [Recent topics on nonalcoholic steatohepatitis]. | 2003 | Details |
A48420 | 11804839 | Am J Physiol Gastrointest Liver Physiol | Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis. | 2002 | Details |
A48527 | 34727968 | BMC Res Notes | Placental extract suppresses the formation of fibrotic deposits by tumor necrosis factor alpha and transforming growth factor beta-induced epithelial-mesenchymal transition in ARPE-19 cells. | 2021 | Details |
A48632 | 32649971 | J Hepatol | Integrative molecular profiling of autoreactive CD4 T cells in autoimmune hepatitis. | 2020 | Details |
A48798 | 28392436 | J Immunol Methods | An oral administration of a recombinant anti-TNF fusion protein is biologically active in the gut promoting regulatory T cells: Results of a phase I clinical trial using a novel oral anti-TNF alpha-based therapy. | 2017 | Details |
A48824 | 27498701 | Sci Rep | Fibroblast growth factor 21 deficiency exacerbates chronic alcohol-induced hepatic steatosis and injury. | 2016 | Details |
A48847 | 26738395 | Br J Biomed Sci | Pentraxin-3 and nitric oxide as indicators of disease severity in alcoholic cirrhosis. | 2015 | Details |
A48857 | 26448681 | Mediators Inflamm | C57BL/6 and A/J Mice Have Different Inflammatory Response and Liver Lipid Profile in Experimental Alcoholic Liver Disease. | 2015 | Details |
A48898 | 25251280 | Hepatology | Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice. | 2015 | Details |
A48908 | 24814604 | Am J Pathol | Adverse signaling of scavenger receptor class B1 and PGC1s in alcoholic hepatosteatosis and steatohepatitis and protection by betaine in rat. | 2014 | Details |
A48911 | 24796378 | Hepatol Res | Inhibition of acidic sphingomyelinase reduces established hepatic fibrosis in mice. | 2014 | Details |
A48916 | 24592262 | Front Immunol | TWEAK and LTβ Signaling during Chronic Liver Disease. | 2014 | Details |
A48921 | 24400890 | J Cell Mol Med | The functional role of microRNAs in alcoholic liver injury. | 2014 | Details |
A48951 | 23388073 | Lipids Health Dis | Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice. | 2013 | Details |
A48963 | 23057725 | Hepatol Res | Fatty liver Shionogi-ob/ob mouse: A new candidate for a non-alcoholic steatohepatitis model. | 2012 | Details |
A48964 | 23027617 | Carcinogenesis | Preventive effects of branched-chain amino acid supplementation on the spontaneous development of hepatic preneoplastic lesions in C57BL/KsJ-db/db obese mice. | 2012 | Details |
A48974 | 22637703 | Gut | Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis. | 2012 | Details |
A48999 | 21951423 | Hepatol Res | Therapeutic effects of ezetimibe for non-alcoholic steatohepatitis in fatty liver shionogi-ob/ob mice. | 2011 | Details |
A49009 | 21466434 | Curr Pharm Biotechnol | Silymarin in the prevention and treatment of liver diseases and primary liver cancer. | 2012 | Details |
A49027 | 20969493 | Scand J Gastroenterol | Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice. | 2010 | Details |
A49083 | 18537187 | Hepatology | Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial. | 2008 | Details |
A49091 | 18336675 | J Gastroenterol Hepatol | Oxidative stress in alcoholic liver disease: role of NADPH oxidase complex. | 2008 | Details |
A49106 | 17435339 | Nihon Yakurigaku Zasshi | [Candidate drugs for non-alcoholic steatohepatitis (NASH)]. | 2007 | Details |
A49141 | 16448457 | Liver Int | The relationship between hepatic immunoglobulin production and CD154 expression in chronic liver diseases. | 2006 | Details |
A49143 | 16340448 | Alcohol Clin Exp Res | -238 G>A polymorphism of tumor necrosis factor alpha gene (TNFA) is associated with alcoholic liver cirrhosis in alcoholic Spanish men. | 2005 | Details |
A49154 | 16137475 | Gastroenterol Hepatol | [Etiopathogenesis of non-alcoholic steatohepatitis]. | 2005 | Details |
A49174 | 15504303 | Zhonghua Gan Zang Bing Za Zhi | [The role of enterogenous endotoxemia in the pathogenesis of non-alcoholic steatohepatitis]. | 2004 | Details |
A49176 | 15475485 | Am J Physiol Gastrointest Liver Physiol | Leptin deficiency enhances sensitivity of rats to alcoholic steatohepatitis through suppression of metallothionein. | 2004 | Details |
A49233 | 35814507 | J Clin Exp Hepatol | Demonstration of Gut-Barrier Dysfunction in Early Stages of Non-alcoholic Fatty Liver Disease: A Proof-Of-Concept Study. | 2022 | Details |
A49234 | 35813333 | Ann Transl Med | Yinzhihuang oral liquid protects against non-alcoholic steatohepatitis via modulation of the gut-liver axis in mice. | 2022 | Details |
A49245 | 35811658 | Dis Markers | Pharmacological Mechanism of Ganlu Powder in the Treatment of NASH Based on Network Pharmacology and Molecular Docking. | 2022 | Details |
A49309 | 35792732 | Biomarkers | Chemical compositions of Commiphora opobalsamum stem bark to alleviate liver complications in streptozotocin-induced diabetes in rats: Role of oxidative stress and DNA damage. | 2022 | Details |
A49352 | 35780841 | Life Sci | Ellagic acid ameliorates high fructose-induced hyperuricemia and non-alcoholic fatty liver in Wistar rats: Focusing on the role of C1q/tumor necrosis factor-related protein-3 and ATP citrate lyase. | 2022 | Details |
A49396 | 35765026 | J Transl Med | Rhubarb free anthraquinones improved mice nonalcoholic fatty liver disease by inhibiting NLRP3 inflammasome. | 2022 | Details |
A49443 | 35748073 | Yonsei Med J | Canagliflozin Ameliorates Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism and Inhibiting Inflammation through Induction of Autophagy. | 2022 | Details |
A49481 | 35740285 | Biomedicines | Rifaximin Improves Spatial Learning and Memory Impairment in Rats with Liver Damage-Associated Neuroinflammation. | 2022 | Details |
A49524 | 35726797 | Food Funct | Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats. | 2022 | Details |
A49534 | 35723052 | Food Funct | Coffee peel extracts ameliorate non-alcoholic fatty liver disease via a fibroblast growth factor 21-adiponectin signaling pathway. | 2022 | Details |